CABALETTA BIO, INC. (CABA): Price and Financial Metrics

CABALETTA BIO, INC. (CABA): $2.71

0.01 (+0.37%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add CABA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#324 of 337

in industry

CABA Price/Volume Stats

Current price $2.71 52-week high $25.05
Prev. close $2.70 52-week low $1.76
Day low $2.70 Volume 1,162,500
Day high $2.88 Avg. volume 1,313,123
50-day MA $2.57 Dividend yield N/A
200-day MA $5.60 Market Cap 132.46M

CABA Stock Price Chart Interactive Chart >


CABALETTA BIO, INC. (CABA) Company Bio


Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.


CABA Latest News Stream


Event/Time News Detail
Loading, please wait...

CABA Latest Social Stream


Loading social stream, please wait...

View Full CABA Social Stream

CABA Price Returns

1-mo -1.09%
3-mo 6.69%
6-mo -54.07%
1-year -88.15%
3-year 11.52%
5-year -83.90%
YTD 19.38%
2024 -90.00%
2023 145.41%
2022 144.06%
2021 -69.63%
2020 -10.67%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!